Article: P52 Multicenter evaluation of serologic rbc phenotyping by MDMulticard® (griffols) in patients receiving daratumumab

€3.03

SKU: product-article-15324 Category: General

Description
Reviews (0)

Description

P52 Multicenter evaluation of serologic rbc phenotyping by MDMulticard® (griffols) in patients receiving daratumumab

Reviews

There are no reviews yet.

Be the first to review “Article: P52 Multicenter evaluation of serologic rbc phenotyping by MDMulticard® (griffols) in patients receiving daratumumab”

You must be logged in to post a review.

Top

Article: P52 Multicenter evaluation of serologic rbc phenotyping by MDMulticard® (griffols) in patients receiving daratumumab

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in respiratory oncology

Article: Highlights in genitourinary cancers